AlphAIAlphAI — Financial news for AI agents
SEC EDGAROCT 191 min read$GRSD

McCrystle Kevin Ross purchased $3K of GRSD

McCrystle Kevin Ross (CEO) purchased 2,901 shares of GRANDSTAND Ltd (GRSD) at $1.16 on 2026-10-15.

Original reporting
SEC EDGAR · McCrystle Kevin Ross
Published Oct 19, 2026, 9:37 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 19, 2026, 9:42 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$GRSD
Neutral
low confidence
Mentioned
$GRSD
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GRSDNeutralLow
01

Why it matters

The filing provides a primary source of insider activity but the dollar amount is trivial, limiting trading relevance.

02

Market read

Minor insider buy; unlikely to move the stock significantly.

03

What to watch

If the CEO is accumulating shares ahead of a strategic move, the signal could become material.

Relevance 4/10Novelty 4/10Timing: immediate filing date

Background

SEC Form 4 filings disclose insider transactions. This filing reports a small open‑market purchase by the CEO of Grandstand Ltd.

Company-level read

Ticker impact

$GRSDNeutralLow confidence
Context

CEO Kevin Ross bought 2,901 shares of Grandstand Ltd for $3,365, increasing his stake to over 1 million shares.

Expected impact

slight upward pressure as the market may view the buy as a positive signal

Evidence & confidence

The transaction amount is small relative to the company's market cap, limiting material impact.

Market effects

Sector

None

Regional

None

Global

None

Counterpoint

What could challenge this read

The purchase could be a routine portfolio adjustment with no real implication for price.

Key entities

  • Company
    Grandstand Ltd

    Micro‑cap firm whose ticker is GRSD.

  • Person
    Kevin Ross

    CEO of Grandstand Ltd who made the purchase.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

GRSD insider trading history →

Related articles

AUG 13
$GRSDMed

GRANDSTAND Ltd (GRSD): Financial results for Q2 2026

GRANDSTAND Ltd (GRSD) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 PRESS RELEASE August 13, 2026 at 4:00 p.m. ET Grandstand Reports Second Quarter Results and Reiterates 2026 Full-Year Guidance 2026 Second Quarter and Recent Highlights • Revenue of $37.8 million in line with expectations • Net loss of $4.6 million and Adjusted net i

SEC EDGAR 6-K2 min
OCT 27
$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).

SEC EDGAR1 min